| Gilead | 60,000 | 2024 | Support to Core Resistance 2024 & Genetic |
| Gilead | 60,000 | 2023 | Support to Core Resistance 2023 & Genetic |
| Gilead | 60,000 | 2022 | Support to Core Resistance 2022 & Genetic |
| Podcasts | 7800 | 2022 | Educational Podcasts supported by Gilead |
| Pfizer | 5000 | 2022 | Katharina Kusejko 1/3 of Pfizer Prize |
| Podcasts | 5400 | 2021 | Educational Podcasts supported by Gilead |
| Gilead | 60,000 | 2021 | Support to Core Resistance 2021 & Genetic |
| ViiV | 695,000 | 2021 | App development for patients enrolled in the SHCS |
| Freedom Forever Association | 6,000 | 2020 | Donation |
| Gilead | 60,000 | 2020 | Support to Core Resistance 2020 & Genetic |
| Gilead | 60,000 | 2019 | Support to Core Resistance 2019 & Genetic |
| Freedom Forever Association | 15,000 | 2019 | Donation |
| Gilead | 40,000 | 2019 | Metabolism and Aging Project Core 2019 |
| Gilead | 40,000 | 2018 | Metabolism and Aging Project Core 2018 |
| AbbVie | 20,000 | 2017 | AbbVie Prize 2017 |
| Gilead | 60,000 | 2017 | Support to Core Resistance 2017 & Genetic |
| Gilead | 40,000 | 2017 | Metabolism and Aging Project Core 2017 |
| AbbVie | 20,000 | 2016 | AbbVie Prize 2016 |
| Gilead | 60,000 | 2016 | Support to Core Resistance 2016 & Genetic |
| Janssen Cilag | 7,000 | 2016 | Metabolism and Aging Project Core 2016 |
| AbbVie | 20,000 | 2015 | AbbVie Prize 2015 |
| Janssen Cilag | 25,000 | 2015 | Metabolism and Aging Project Core 2015 |
| AbbVie | 30,000 | 2015 | SHCS HIV/HCV 2015 |
| Gilead | 40,000 | 2015 | Metabolism and Aging Project Core 2016 |
| Gilead | 60,000 | 2015 | Support to Core Resistance 2015 & Genetic |
| Gilead | 60,000 | 2014 | Support to Metabolism and Aging Project Core 2014 |
| BMS | 10,000 | 2014 | Metabolism and Aging Project Core 2014 |
| MSD | 20,000 | 2014 | Metabolism and Aging Project Core 2014 |
| Janssen Cilag | 25,000 | 2014 | Metabolism and Aging Project Core 2014 |
| MSD | 30,000 | 2014 | Support to Core Resistance 2013 & Genetic |
| MSD | 20,000 | 2014 | Metabolism and Aging Project Core 2013 |
| MSD | 30,000 | 2014 | Support to Core Resistance 2014 & Genetic |
| ViiV | 600,000 | 2014 | Support for SHCS projects |
| Gilead | 60,000 | 2013 | Support to Core Resistance 2013 & Genetic |
| AbbVie | 20,000 | 2013 | AbbVie Prize 2014 |
| AbbVie | 25,000 | 2013 | Metabolism and Aging Project Core 2014 |
| Abbott | 150,000 | 2013 | Metabolism and Aging Project Core (6 years x 25,000) |
| AbbVie | 25,000 | 2013 | Metabolism and Aging Project Core 2013 |
| Gilead | 20,000 | 2013 | Metabolism and Aging Project Core 2013 |
| AbbVie | 30,000 | 2012 | AbbVie Prize 2013 |
| MSD | 25,000 | 2012 | Support to Core Resistance 2012 & Genetic |
| MSD | 50,000 | 2012 | Metabolism and Aging Project Core paid directly to Bruderholz |
| SSI | 12,210 | 2012 | |
| BMS | 15,000 | 2012 | Metabolism and Aging Project Core |
| Abbott | 25,000 | 2012 | Metabolism and Aging Project Core |
| Gilead | 20,000 | 2012 | Metabolism and Aging Project Core |
| Gilead | 60,000 | 2012 | Support to Core Resistance 2012 & Genetic |
| Abbott | 50,000 | 2011 | Abbott Prize 2011 |
| Abbott | 50,000 | 2011 | Abbott Prize 2012 |
| Gilead | 60,000 | 2011 | Support to Core Resistance 2011 & Osteoright 11 |
| Gilead | 60,000 | 2010 | Support to Core Resistance & Genetic 2010 |
